Worldwide Human Growth Hormone Market Examined in Topical Study by Rockville Research Published at MarketPublishers.com

20 Mar 2017 • by Natalie Aster

LONDON – Due to growth stimulating characteristics of HGH (or somatotropin), superfluous secretion results in acromegalic gigantism; whilst the shortage of GH results in growth hormone deficiency (GHD) – a chronic illness afflicting both kids and adults. GHD during childhood is characterised by decreased growth performance and a loss in height over against peers. GHD in adults displays symptoms such as weight increase, reduced levels of energy, sleep disruption, amid others. Standard treatments for GHD encompass the administration of recombinant HGH (rHGH) through injections, sprays, releasers, etc. 

The global HGH market growth is fuelled by an upsurge in the prevalence rate of pituitary disorder, soaring ageing population, significant market opportunities owing to lower rHGH market penetration rate across countries, growing healthcare spending and affordability. Key factors limiting the market growth are high treatment cost of rHGH, negative side-effects of synthetic HGH, illegal usage of HGH, poor adherence to treatment by patients and stiff regulatory approvals involved.

The US is the largest HGH market worldwide, grabbing over one-third of the total HGH market value.

Novo Nordisk, Merck Serono, Pfizer, Eli Lilly and Hoffmann-La Roche Ltd. are the leading players in the marketplace.

Topical market research publication “Global Human Growth Hormone (HGH) Market Outlook 2022” drawn up by Rockville Research provides deep, granular insights into the market on a global level, focusing on the USA, Europe, and Japan.

The study offers an in-depth, comprehensive examination of global HGH market, focusing on adult and pediatric GHD. The report provides a comprehensive analysis of the key industry trends and developments restraining and driving factors, as well as their influence on the market growth in the years to come. Additionally, the study sheds light on the different market specific growth opportunities at the global level and region-wise. The report examines the market landscape, covering an analysis of brands, drugs by disorders, as well as market shares by competitors.

More detailed market research reports by this publisher can be found in Rockville Research online catalogue at MarketPublishers.com.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com